178 related articles for article (PubMed ID: 36342564)
1. Esophageal mast cells may be associated with the perception of symptoms in patients with eosinophilic esophagitis.
Kanamori A; Tanaka F; Takashima S; Sawada A; Ominami M; Nadatani Y; Fukunaga S; Otani K; Hosomi S; Kamata N; Nagami Y; Taira K; Watanabe T; Fujiwara Y
Esophagus; 2023 Apr; 20(2):333-341. PubMed ID: 36342564
[TBL] [Abstract][Full Text] [Related]
2. Tryptase staining of mast cells may differentiate eosinophilic esophagitis from gastroesophageal reflux disease.
Dellon ES; Chen X; Miller CR; Fritchie KJ; Rubinas TC; Woosley JT; Shaheen NJ
Am J Gastroenterol; 2011 Feb; 106(2):264-71. PubMed ID: 20978486
[TBL] [Abstract][Full Text] [Related]
3. Increased numbers of eosinophils, rather than only etiology, predict histologic changes in patients with esophageal eosinophilia.
Sridhara S; Ravi K; Smyrk TC; Kita H; Kephart GM; Weiler CR; Katzka DA
Clin Gastroenterol Hepatol; 2012 Jul; 10(7):735-41. PubMed ID: 22289868
[TBL] [Abstract][Full Text] [Related]
4. Elevated Tryptase in EoE Is an Independent Phenomenon Associated with Extra-Esophageal Symptoms.
Kutty GR; Downs-Kelly E; Crispin HT; Peterson KA
Dig Dis Sci; 2019 Jan; 64(1):152-157. PubMed ID: 30267171
[TBL] [Abstract][Full Text] [Related]
5. Mast Cell Infiltration Is Associated With Persistent Symptoms and Endoscopic Abnormalities Despite Resolution of Eosinophilia in Pediatric Eosinophilic Esophagitis.
Bolton SM; Kagalwalla AF; Arva NC; Wang MY; Amsden K; Melin-Aldana H; Dellon ES; Bryce PJ; Wershil BK; Wechsler JB
Am J Gastroenterol; 2020 Feb; 115(2):224-233. PubMed ID: 31913192
[TBL] [Abstract][Full Text] [Related]
6. Anti-IL-5 therapy reduces mast cell and IL-9 cell numbers in pediatric patients with eosinophilic esophagitis.
Otani IM; Anilkumar AA; Newbury RO; Bhagat M; Beppu LY; Dohil R; Broide DH; Aceves SS
J Allergy Clin Immunol; 2013 Jun; 131(6):1576-82. PubMed ID: 23623266
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological Differences between Eosinophilic Esophagitis and Asymptomatic Esophageal Eosinophilia.
Suzuki Y; Iizuka T; Hosoi A; Kikuchi D; Okamura T; Ochiai Y; Hayasaka J; Dan N; Mitsunaga Y; Tanaka M; Odagiri H; Nomura K; Yamashita S; Matsui A; Hoteya S
Intern Med; 2022 May; 61(9):1319-1327. PubMed ID: 34670895
[TBL] [Abstract][Full Text] [Related]
8. Mast Cell and Eosinophil Counts in Gastric and Duodenal Biopsy Specimens From Patients With and Without Eosinophilic Gastroenteritis.
Reed CC; Genta RM; Youngblood BA; Wechsler JB; Dellon ES
Clin Gastroenterol Hepatol; 2021 Oct; 19(10):2102-2111. PubMed ID: 32801015
[TBL] [Abstract][Full Text] [Related]
9. Markers of eosinophilic inflammation for diagnosis of eosinophilic esophagitis and proton pump inhibitor-responsive esophageal eosinophilia: a prospective study.
Dellon ES; Speck O; Woodward K; Covey S; Rusin S; Gebhart JH; Chen X; Woosley JT; Shaheen NJ
Clin Gastroenterol Hepatol; 2014 Dec; 12(12):2015-22. PubMed ID: 24993367
[TBL] [Abstract][Full Text] [Related]
10. Serum eosinophil cationic protein is superior to mast cell tryptase as marker for response to topical corticosteroid therapy in eosinophilic esophagitis.
Schlag C; Pfefferkorn S; Brockow K; Haller B; Slotta-Huspenia J; Schulz S; von Werder A; Ring J; Schmid RM; Bajbouj M
J Clin Gastroenterol; 2014 Aug; 48(7):600-6. PubMed ID: 24177377
[TBL] [Abstract][Full Text] [Related]
11. Expression of CD25, mast cell markers and T-cell markers in eosinophilic esophagitis.
Htoo A; Qualia CM; George R; Arker SH; Subasi NB; Lee H; Chung L; Chen A
Ann Diagn Pathol; 2024 Jun; 70():152287. PubMed ID: 38479198
[TBL] [Abstract][Full Text] [Related]
12. Eosinophilic esophagitis and asymptomatic esophageal eosinophilia display similar immunohistological profiles.
Kitamura H; Tanaka F; Nadatani Y; Otani K; Hosomi S; Kamata N; Taira K; Nagami Y; Tanigawa T; Fukumoto S; Watanabe T; Kawada N; Fujiwara Y
J Clin Biochem Nutr; 2021 May; 68(3):246-252. PubMed ID: 34025028
[TBL] [Abstract][Full Text] [Related]
13. Vasoactive Intestinal Peptide Receptor, CRTH2, Antagonist Treatment Improves Eosinophil and Mast Cell-Mediated Esophageal Remodeling and Motility Dysfunction in Eosinophilic Esophagitis.
Yadavalli CS; Upparahalli Venkateshaiah S; Verma AK; Kathera C; Duncan PS; Vaezi M; Paul RJ; Mishra A
Cells; 2024 Feb; 13(4):. PubMed ID: 38391908
[TBL] [Abstract][Full Text] [Related]
14. Pediatric Eosinophilic Esophagitis Symptom Scores (PEESS v2.0) identify histologic and molecular correlates of the key clinical features of disease.
Martin LJ; Franciosi JP; Collins MH; Abonia JP; Lee JJ; Hommel KA; Varni JW; Grotjan JT; Eby M; He H; Marsolo K; Putnam PE; Garza JM; Kaul A; Wen T; Rothenberg ME
J Allergy Clin Immunol; 2015 Jun; 135(6):1519-28.e8. PubMed ID: 26051952
[TBL] [Abstract][Full Text] [Related]
15. Atopic and non-atopic eosinophilic oesophagitis are distinguished by immunoglobulin E-bearing intraepithelial mast cells.
Mulder DJ; Mak N; Hurlbut DJ; Justinich CJ
Histopathology; 2012 Nov; 61(5):810-22. PubMed ID: 22978418
[TBL] [Abstract][Full Text] [Related]
16. Machine learning-based identification and characterization of mast cells in eosinophilic esophagitis.
Zhang S; Caldwell JM; Rochman M; Collins MH; Rothenberg ME
J Allergy Clin Immunol; 2024 May; 153(5):1381-1391.e6. PubMed ID: 38395083
[TBL] [Abstract][Full Text] [Related]
17. MAST CELLS DISTINGUISH EOSINOPHILIC ESOPHAGITIS IN PEDIATRIC PATIENTS.
Lomazi EA; Brandalise NA; Servidoni MFPC; Cardoso SR; Meirelles LR
Arq Gastroenterol; 2017; 54(3):192-196. PubMed ID: 28492714
[TBL] [Abstract][Full Text] [Related]
18. Endoscopic findings in patients with Schatzki rings: evidence for an association with eosinophilic esophagitis.
Müller M; Eckardt AJ; Fisseler-Eckhoff A; Haas S; Gockel I; Wehrmann T
World J Gastroenterol; 2012 Dec; 18(47):6960-6. PubMed ID: 23322994
[TBL] [Abstract][Full Text] [Related]
19. Pathogenic role of mast cells in experimental eosinophilic esophagitis.
Niranjan R; Mavi P; Rayapudi M; Dynda S; Mishra A
Am J Physiol Gastrointest Liver Physiol; 2013 Jun; 304(12):G1087-94. PubMed ID: 23599040
[TBL] [Abstract][Full Text] [Related]
20. Mucosal and Submucosal Thickening of Esophageal Wall Is a Promising Factor in the Development of Symptoms in Eosinophilic Esophagitis.
Suzuki Y; Ochiai Y; Hosoi A; Okamura T; Hayasaka J; Mitsunaga Y; Tanaka M; Odagiri H; Nomura K; Yamashita S; Matsui A; Kikuchi D; Ohashi K; Hoteya S
Gut Liver; 2024 Jan; 18(1):50-59. PubMed ID: 36789578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
